Genetic susceptibility, risk prediction, and druggable targets for oropharyngeal cancer: a UK Biobank study
European Archives of Oto-Rhino-Laryngology · 04.10.2026
DOI: 10.1007/s00405-026-10663-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Archives of Oto-Rhino-Laryngology, online erschienen am 04.10.2026. Verfasst von Junhong Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head & Neck Surgery, and, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Che…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Department of Sichuan Province, Chengdu Science and Technology Bureau.
Abstract (Originalsprache)
PURPOSE: This study aimed to systematically identify and annotate oropharyngeal cancer (OPC) genetic risk, construct OPC risk prediction models, and identify candidate drug targets for OPC treatment. METHODS: The OPC genome-wide association study was conducted in the UK Biobank involving 208 OPC patients and 328,248 healthy individuals. Functional annotations were performed using the FUMA website and the Sclinker statistical framework. OPC risk prediction models were constructed using logistic regression. Mendelian randomization (MR) was employed to identify potential OPC-related drug target genes. RESULTS: We identified 43 OPC risk genetic variants with p < 1E-06, which mapped to 7 independent loci. We also revealed significant tissue-level OPC single nucleotide polymorphism heritability enrichments in heart, kidney, and muscle, and cell-type specific enrichments in B cells, T cells, endothelial cells, epithelial cells, and fibroblasts. We further constructed four OPC risk prediction models, and the fully-adjusted model demonstrated moderate discriminative ability in internal validation. Additionally, MR analysis identified 160 nominate OPC-associated candidate druggable genes using expression/protein quantitative trait loci as instrumental variables. Drugs targeting these genes, such as Daunorubicin, Gefitinib, and Ibrutinib had been approved as anti-cancer agents. CONCLUSION: These results advanced our understanding of the genetic architecture of OPC and provided insights into its risk prediction and potential drug targets, contributing to future development of improved OPC prevention and treatment strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head & Neck Surgery, and, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China.
- Department of Biostatistics, Princess Margaret Cancer Centre and Dalla Lana School of Public Health, Toronto, ON, Canada. Wei.Xu@uhnresearch.ca.
- Department of Otolaryngology-Head & Neck Surgery, and, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China. yuzhao@wchscu.edu.cn.
- Department of Otolaryngology-Head & Neck Surgery, and, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China. Jianjun.Ren@scu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Science and Technology Department of Sichuan Province
- Chengdu Science and Technology Bureau
- 1·3·5 project for disciplines of excellence-Clinical Research Fund, West China Hospital, Sichuan University
- 1·3·5 project for disciplines of excellence, West China Hospital, Sichuan University
- Sichuan University Interdisciplinary Innovation Fund
Zitieren
APA
Li, J., Qiu, K., Rao, Y., Cheng, D., Song, Y., Shao, X., Jiang, C., Shu, T., Xu, W., Zhao, Y., & Ren, J. (2026). Genetic susceptibility, risk prediction, and druggable targets for oropharyngeal cancer: a UK Biobank study. European Archives of Oto-Rhino-Laryngology. https://doi.org/10.1007/s00405-026-10663-5
Vancouver
Li J, Qiu K, Rao Y, Cheng D, Song Y, Shao X, et al. Genetic susceptibility, risk prediction, and druggable targets for oropharyngeal cancer: a UK Biobank study. European Archives of Oto-Rhino-Laryngology. 2026. doi:10.1007/s00405-026-10663-5
BibTeX
@article{Li2026,
author = {Li, Junhong and Qiu, Ke and Rao, Yufang and Cheng, Danni and Song, Yao and Shao, Xiuli and Jiang, Chuanhuan and Shu, Tao and Xu, Wei and Zhao, Yu and Ren, Jianjun},
title = {Genetic susceptibility, risk prediction, and druggable targets for oropharyngeal cancer: a UK Biobank study},
journal = {European Archives of Oto-Rhino-Laryngology},
year = {2026},
doi = {10.1007/s00405-026-10663-5}
}
EUVIMED